Oaktree Acquisition Corp. III Life Sciences (OACC) said Wednesday it priced its initial public offering of 17.5 million units at $10 per unit.
Each unit comprises one class A ordinary share and one-fifth of a redeemable warrant. Each warrant entitles the holder to purchase one class A share at $11.50 per share, according to the special purpose acquisition company.
The units will be listed on the Nasdaq Global Market this Thursday under the ticker symbol, "OACCU." Once the securities comprising the units begin trading separately, the class A shares and warrants will trade under the symbols "OACC" and "OACCW," respectively.
The offering is set to close Friday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。